Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies.
Stie. Jamal J; Jesaitis. Andrew V AV; Lord. Connie I CI; Gripentrog. Jeannie M JM; Taylor. Ross M RM; Burritt. James B JB; Jesaitis. Algirdas J AJ
Key Findings
- fMLF‑stimulated neutrophils display hCAP‑18 on their surface
- Surface‑bound hCAP‑18 is resistant to high salt but removed by alkaline treatment, suggesting a protein‑protein interaction
- About 25% of cellular hCAP‑18 is released from granules, with portions ending up in the media, membrane, or remaining in granules
Practical Outcomes
- For biohackers, this means LL‑37 may have effects both as a free peptide and when attached to immune cell surfaces, potentially influencing inflammation and immunity. However, the work doesn’t change dosing or supplementation strategies; it mainly adds mechanistic insight.
Summary
The study shows that the precursor protein hCAP-18, which releases the LL‑37 peptide, moves to the surface of neutrophils when they’re activated, sticking there through a likely protein‑protein link. This surface binding is stable against salt but breaks down with strong base, hinting it’s part of the cell’s membrane machinery. While interesting for understanding how LL‑37 works in the body, the findings don’t give direct guidance on how to take or dose the peptide for health benefits.
Abstract
The well-described antimicrobial and immunoregulatory properties of human cathelicidin antimicrobial protein 18 (hCAP-18) derive in part from the ability of its proteolytic fragment, LL-37 (a.k.a. CAP-37), to associate with activated immune and epithelial cells during inflammation. We now show a stable association between hCAP-18 and the cell surface of formyl-Met-Leu-Phe (fMLF)-stimulated neutrophils using two novel hCAP-18-specific mAb, H7 and N9, which recognize a single 16-kDa band, identified by N-terminal sequencing and mass spectrometry as hCAP-18. Phage display analysis of epitope-binding sites showed that both mAb probably recognize a similar five amino acid sequence near the C terminus of the prodomain. Immunoblot analysis of degranulated neutrophil supernatants resulted in mAb recognition of the 14-kDa prodomain of hCAP-18. Subcellular fractionation of unstimulated neutrophils on density gradients showed expected cosedimentation of hCAP-18 with specific granule lactoferrin (LF). fMLF stimulation resulted in an average 25% release of specific granule hCAP-18, with approximately 15% of the total cellular hCAP-18 recovered from culture media, and approximately 10% and approximately 75%, respectively, codistributing with plasma membrane alkaline phosphatase and specific granule LF. Surface association of hCAP-18 on fMLF-stimulated neutrophils was confirmed by immunofluorescence microscopy and flow cytometry analysis, which also suggested a significant up-regulation of surface hCAP-18 on cytochalasin B-pretreated, fully degranulated neutrophils. hCAP-18 surface association was labile to 10 mM NaOH treatment but resistant to 1 M NaCl and also partitioned into the detergent phase following Triton X-114 solubilization, possibly suggesting a stable association with one or more integral membrane proteins. We conclude that fMLF stimulation promotes redistribution of hCAP-18 to the surface of human neutrophils.
Study Information
pubmed
2007
2007-03-30T00:00:00.000Z
10.1189/jlb.0906586
8
67